Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Alliance Grants

McGill University

$50,000.00

Rapid detection of COVID-19 using an isothermal amplification-based lateral flow assay_x000d_

EF 2020-21

Résumé
The highly transmitted and lethal coronavirus disease COVID-19 caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been declared as a global pandemic by the World Health Organization (WHO) on March 11th. Rapid detection of this SARS-CoV-2 has been recommended as the key to prevent its community spread and to win this battle against the virus. The gold standard detection method for this virus widely adopted by public health agencies is based on reverse transcription-polymerase chain reaction. Although reliable, this method suffers the disadvantages of requiring sophisticated instrument for stringent thermal cycling, highly trained personnel, and relatively long reaction time (2-4 hours). These have impaired Canada to test a large population of citizens on a daily basis. To address these drawbacks, we proposed to develop a novel detection method based on an isothermal amplification mechanism, recombinase polymerase amplification (RPA), which can amplify nucleic acid at a constantly low temperature (37~42 degree celsius) in a much more rapid manner (<20 minutes). Combining with a lateral flow immunoassay (LFI), the nucleic acid amplicons of RPA can be visualized in a few minutes without the requirement of other instruments for amplicon detection. We anticipate this novel RPA-LFI method to provide comparable sensitivity and specificity as compared to the gold standard method, while substantially reduce the analytical time and simplify the analysis procedure. This novel detection method will not only benefit Canada to combat COVID-19 amid the pandemic, but also provide a promising alternative for routine surveillance and monitoring of this public health threat in resource-limited conditions.
Programme
Alliance Grants
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
554324-2020
Name nom
Lu, Xiaonan
Department département
Food Science and Agricultural Chemistry
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2020
Award amount
50000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
9000
Research subject group en
Medical sciences
Research subject group fr
Sciences médicales
Research subject en
Medical sciences
Research subject fr
Sciences médicales
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Rapid detection of COVID-19 using an isothermal amplification-based lateral flow assay_x000d_
Keyword
NSERC
Application summary
The highly transmitted and lethal coronavirus disease COVID-19 caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been declared as a global pandemic by the World Health Organization (WHO) on March 11th. Rapid detection of this SARS-CoV-2 has been recommended as the key to prevent its community spread and to win this battle against the virus. The gold standard detection method for this virus widely adopted by public health agencies is based on reverse transcription-polymerase chain reaction. Although reliable, this method suffers the disadvantages of requiring sophisticated instrument for stringent thermal cycling, highly trained personnel, and relatively long reaction time (2-4 hours). These have impaired Canada to test a large population of citizens on a daily basis. To address these drawbacks, we proposed to develop a novel detection method based on an isothermal amplification mechanism, recombinase polymerase amplification (RPA), which can amplify nucleic acid at a constantly low temperature (37~42 degree celsius) in a much more rapid manner (<20 minutes). Combining with a lateral flow immunoassay (LFI), the nucleic acid amplicons of RPA can be visualized in a few minutes without the requirement of other instruments for amplicon detection. We anticipate this novel RPA-LFI method to provide comparable sensitivity and specificity as compared to the gold standard method, while substantially reduce the analytical time and simplify the analysis procedure. This novel detection method will not only benefit Canada to combat COVID-19 amid the pandemic, but also provide a promising alternative for routine surveillance and monitoring of this public health threat in resource-limited conditions.